richardwilliam93 Criou um novo artigo
1 y

Biogen begins ISIS-SOD1Rx Phase I/II trial to treat ALS | #superoxide Dismutase drugs development Market

Biogen begins ISIS-SOD1Rx Phase I/II trial to treat ALS

Biogen begins ISIS-SOD1Rx Phase I/II trial to treat ALS

Superoxide dismutase is used for treating pain and swelling (inflammation) caused by osteoarthritis, sports injuries, rheumatoid arthritis, interstitial cystitis, gout, cancer, lung problems in newborns, and poisoning caused by a weed-killer called paraquat.